What is the 13F Pro Quality Score for SNYR?

13F Pro ranks Synergy CHC Corp. (SNYR) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SNYR's current score at https://13fpro.ai/research/SNYR (free sign-up required for the full ranking).

Which hedge funds own the most SNYR stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of SNYR include GRATIA CAPITAL,, HEARTLAND ADVISORS, SANDERS MORRIS HARRIS. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/SNYR as soon as new 13F filings post.

Where does 13F Pro source SNYR data?

All Synergy CHC Corp. fundamentals and ownership data come directly from SEC EDGAR. Synergy CHC Corp. files with the SEC under CIK 1562733. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SNYR in?

Synergy CHC Corp. (SNYR) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SNYR research updated on 13F Pro?

SNYR's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Synergy CHC Corp.(SNYR)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1562733 SNYR stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $42.8M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

SNYR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Synergy CHC Corp. (SNYR), a Healthcare sector company. SNYR is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $42.8m in revenue. Based on the latest XBRL financial filings (Q1 2026), Synergy CHC Corp. reports quarterly revenue of $5.5M, net income of $-2.6M, free cash flow of $-2.0M. Top institutional holders of SNYR by reported 13-F value include GRATIA CAPITAL,, HEARTLAND ADVISORS, SANDERS MORRIS HARRIS, based on the most recent SEC filings. SNYR trades on the Nasdaq exchange and files with the SEC under CIK 1562733. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNYR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Synergy CHC Corp. directly from SEC EDGAR.

Revenue

Q1 2026

$5.5M

Net Income

Q1 2026

$-2.6M

Free Cash Flow

Q1 2026

$-2.0M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-29.9% YoY

$30.0MFY 2024

FY19 $29.4MFY22 —FY23 $42.8MFY24 $30.0M

Net Income

-66.5% YoY

$2.1MFY 2024

FY19 $-9.2MFY22 —FY23 $6.3MFY24 $2.1M

Operating Income

-46.3% YoY

$5.8MFY 2024

FY19 $-8.0MFY22 —FY23 $10.8MFY24 $5.8M

EPS (Diluted)

-67.4% YoY

$0.28FY 2024

FY19 $-0.10FY22 —FY23 $0.86FY24 $0.28

Total Assets

+33.5% YoY

$16.3MFY 2024

FY19 $5.2MFY22 —FY23 $12.2MFY24 $16.3M

Total Debt

+11.0% YoY

$19.2MFY 2024

FY19 $5.5MFY22 —FY23 $17.3MFY24 $19.2M

Op. Cash Flow

-1239.0% YoY

$-4.8MFY 2024

FY19 $2.9MFY22 —FY23 $421.7KFY24 $-4.8M

Metric	FY 2024	FY 2023	FY 2022	FY 2019	FY 2018	FY 2016
Revenue	$30.0M -29.9%	$42.8M	—	$29.4M -13.2%	$33.8M -2.9%	$34.8M
Net Income	$2.1M -66.5%	$6.3M	—	$-9.2M -49.5%	$-6.2M -673.8%	$-796.2K
Operating Income	$5.8M -46.3%	$10.8M	—	$-8.0M -61.8%	$-4.9M -267.6%	$2.9M
EPS (Diluted)	$0.28 -67.4%	$0.86	—	$-0.10 -42.9%	$-0.07	—
Total Assets	$16.3M +33.5%	$12.2M	—	$5.2M -74.1%	$20.0M -2.2%	$20.5M
Total Debt	$19.2M +11.0%	$17.3M	—	$5.5M +19270.9%	$28.2K -96.2%	$750.0K
Operating Cash Flow	$-4.8M -1239.0%	$421.7K	—	$2.9M +125.8%	$1.3M -78.4%	$6.0M

AI Insight: SNYR Financial Trends

Synergy CHC reversed to losses in Q4 2025–Q1 2026 after brief profitability, while debt surged 80% from Q1 2025 to Q3 2025.

• Net income swung from +$1M in Q1 2025 to –$15M in Q4 2025, then –$3M in Q1 2026.

• Total debt climbed from $16M in Q1 2025 to $37M by Q3 2025, then moderated to $25M by Q1 2026.

• Operating income contracted from +$2M in Q1–Q2 2025 to –$13M in Q4 2025 and –$1M in Q1 2026.

⚠ Operating cash flow has been negative or near-zero for five consecutive quarters; Q1 2026 showed –$2M.

⚠ Equity deficit widened to –$25M in Q1 2026, matching Q1 2020 lows, signaling balance-sheet strain.

AI Insight: SNYR Ratio Trends

Operating margin collapsed to -10.3% in Q1 2026, marking a severe deterioration from 16.0% just one quarter prior.

• Net profit margin plunged to -46.8% in Q1 2026 from 1.6% in Q3 2025, indicating acute profitability distress.

• ROA swung wildly: 29.9% in Q2 2025, collapsed to 2.4% in Q3 2025, then disappeared in Q4 2025 and Q1 2026.

⚠ Operating margin deterioration from +16.0% to -10.3% in two quarters suggests operational/cost-control breakdown requiring immediate investigation.

⚠ ROIC halved from 35.1% (Q2 2025) to 17.9% (Q3 2025)—first material decline in the tracked period signals capital efficiency erosion.

Get alerted when SNYR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Synergy CHC Corp. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SNYR

GRATIA CAPITAL, LLC
$709.5K550,000 sh
HEARTLAND ADVISORS INC
$709.5K550,000 sh
SANDERS MORRIS HARRIS LLC
$535.9K415,452 sh
VANGUARD CAPITAL MANAGEMENT LLC
$115.8K89,770 sh
VANGUARD FIDUCIARY TRUST CO
$29.9K23,149 sh
GEODE CAPITAL MANAGEMENT, LLC
$27.6K21,398 sh
Warberg Asset Management LLC
$13.2K10,222 sh
Williams & Novak, LLC
$12.2K11,945 sh
Tower Research Capital LLC (TRC)
$3.7K2,892 sh
UBS Group AG
$1.2K900 sh

Fund	Value	Shares
GRATIA CAPITAL, LLC	$709.5K	550,000
HEARTLAND ADVISORS INC	$709.5K	550,000
SANDERS MORRIS HARRIS LLC	$535.9K	415,452
VANGUARD CAPITAL MANAGEMENT LLC	$115.8K	89,770
VANGUARD FIDUCIARY TRUST CO	$29.9K	23,149
GEODE CAPITAL MANAGEMENT, LLC	$27.6K	21,398
Warberg Asset Management LLC	$13.2K	10,222
Williams & Novak, LLC	$12.2K	11,945
Tower Research Capital LLC (TRC)	$3.7K	2,892
UBS Group AG	$1.2K	900

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SNYR on your watchlist

Track score changes the day Synergy CHC Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SNYR a good stock to buy?

13F Pro's AI-powered analysis of Synergy CHC Corp. (SNYR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SNYR are available on the SNYR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own SNYR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SNYR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Synergy CHC Corp.'s investment landscape.